Anti-inflammatory medication adherence, healthcare utilization and expenditures among medicaid and children's health insurance program enrollees with asthma

PharmacoEconomics

Volumn 30, Issue 5, 2012, Pages 397-412

  Herndon, Jill Boylston ^a   Mattke, Soeren ^b   Evans Cuellar, Alison ^b,c   Hong, Seo Yeon ^b   Shenkman, Elizabeth A ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b RAND CORPORATION   (United States)

^c GEORGE MASON UNIVERSITY   (United States)

Author keywords

Asthma; Children; Corticosteroids; Cost analysis; Inhalation; Leukotriene D4 receptor antagonists

Indexed keywords

CORTICOSTEROID; LEUKOTRIENE RECEPTOR BLOCKING AGENT;

ADOLESCENT; ADULT; ALLERGY; ANXIETY; ARTICLE; ASTHMA; CHILD; COMORBIDITY; COST BENEFIT ANALYSIS; COST MINIMIZATION ANALYSIS; CYSTIC FIBROSIS; EMERGENCY WARD; FEMALE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEALTH PROGRAM; HEALTH STATUS; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAID; MONOTHERAPY; OBESITY; PATIENT COMPLIANCE; PRESCRIPTION; PRIORITY JOURNAL; SICKLE CELL ANEMIA;

ADOLESCENT; ANTI-INFLAMMATORY AGENTS; ASTHMA; CHILD; CHILD, PRESCHOOL; FEMALE; HEALTH CARE COSTS; HEALTH SERVICES; HUMANS; INSURANCE, HEALTH; MALE; MEDICAID; MEDICATION ADHERENCE; UNITED STATES;

EID: 84859805904     PISSN: 11707690     EISSN: 11792027     Source Type: Journal    
DOI: 10.2165/11586660-000000000-00000     Document Type: Article

References (36)

1. Bloom B, Cohen RA, Freeman G. Summary health statistics for U.S. children: national health interview survey, 2008. Vital Health Stat 2009; 10 (244): 1-81
2. Adams RJ, Fuhlbrigge A, Finkelstein JA, et al. Impact of inhaled antiinflammatory therapy on hospitalization and emergency department visits for children with asthma. Pediatrics 2001 Apr; 107 (4): 706-11
3. Balkrishnan R, Norwood GJ, Anderson A. Outcomes and cost benefits associated with the introduction of inhaled corticosteroid therapy in a medicaid population of asthmatic patients. Clin Ther 1998 May-Jun; 20 (3): 567-80
4. Smith MJ, Rascati KL, McWilliams BC. Inhaled antiinflammatory pharmacotherapy and subsequent hospitalizations and emergency department visits among patients with asthma in the Texas Medicaid program. Ann Allergy Asthma Immunol 2004 Jan; 92 (1): 40-6
5. Finkelstein JA, Barton MB, Donahue JG, et al. Comparing asthma care for Medicaid and non-Medicaid children in a health maintenance organization. Arch Pediatr Adolesc Med 2000 Jun; 154 (6): 563-8
6. Ortega AN, Belanger KD, Paltiel AD, et al. Use of health services by insurance status among children with asthma. Med Care 2001 Oct; 39 (10): 1065-74
7. David C. Preventive therapy for asthmatic children under Florida Medicaid: changes during the 1990s. J Asthma 2004 Sep; 41 (6): 655-61
8. Sherman J, Patel P, Hutson A, et al. Adherence to oral montelukast and inhaled fluticasone in children with persistent asthma. Pharmacotherapy 2001 Dec; 21 (12): 1464-7
9. Adams RJ, Fuhlbrigge A, Finkelstein JA, et al. Use of inhaled anti-inflammatory medication in children with asthma in managed care settings. Arch Pediatr Adolesc Med 2001 Apr; 155 (4): 501-7
10. Butz AM, Tsoukleris M, Donithan M, et al. Patterns of inhaled antiinflammatory medication use in young underserved children with asthma. Pediatrics 2006 Dec; 118 (6): 2504-13
11. Finkelstein JA, Lozano P, Farber HJ, et al. Underuse of controller medications among Medicaid-insured children with asthma. Arch Pediatr Adolesc Med 2002 Jun; 156 (6): 562-7
12. Halterman JS, Auinger P, Conn KM, et al. Inadequate therapy and poor symptom control among children with asthma: findings from a multistate sample. Ambul Pediatr 2007 Mar-Apr; 7 (2): 153-9
13. Reeves MJ, Bohm SR, Korzeniewski SJ, et al. Asthma care and management before an emergency department visit in children in western Michigan: how well does care adhere to guidelines? Pediatrics 2006 Apr; 117 (4 Pt 2): S118-26
14. Camargo Jr CA, Ramachandran S, Ryskina KL, et al. Association between common asthma therapies and recurrent asthma exacerbations in children enrolled in a state Medicaid plan. Am J Health Syst Pharm 2007 May 15; 64 (10): 1054-61
15. Smith K, Warholak T, Armstrong E, et al. Evaluation of risk factors and health outcomes among persons with asthma. J Asthma 2009 Apr; 46 (3): 234-7
16. National Asthma Education and Prevention Program, National Institutes of Health, National Heart, Lung and Blood Institute. Expert panel report guidelines for the diagnosis and management of asthma. Bethesda (MD): US Department of Health and Human Services, 2007. NIH publication no.: 08-4051
17. Fitzpatrick AM, Kir T, Naeher LP, et al. Tablet and inhaled controller medication refill frequencies in children with asthma. J Pediatr Nurs 2009 Apr; 24 (2): 81-9
18. Bukstein DA, Luskin AT, Bernstein A. ''Real-world'' effectiveness of daily controller medicine in children with mild persistent asthma. Ann Allergy Asthma Immunol 2003 May; 90 (5): 543-9
19. Balkrishnan R, Nelsen LM, Kulkarni AS, et al. Outcomes associated with initiation of different controller therapies in a Medicaid asthmatic population: a retrospective data analysis. J Asthma 2005 Feb; 42 (1): 35-40
20. Shields AE, Comstock C, Finkelstein JA, et al. Comparing asthma care provided to Medicaid-enrolled children in a primary care case manager plan and a staff model HMO. Ambul Pediatr 2003 Sep-Oct; 3 (5): 253-62
21. Hess LM, Raebel MA, Conner DA, et al. Measurement of adherence in pharmacy administrative databases: a proposal for standard definitions and preferred measures. Ann Pharmacother 2006 Jul-Aug; 40 (7-8): 1280-8
22. Mattke S, Jain AK, Sloss EM, et al. Effect of disease management on prescription drug treatment: what is the right quality measure? Dis Manag 2007 Apr; 10 (2): 91-100
23. Shenkman E, Knapp C, Sappington D, et al. Persistence of high health care expenditures among children in Medicaid. Med Care Res Rev 2007 Jun; 64 (3): 304-30
24. Newhouse JP, Manning WG, Keeler EB, et al. Adjusting capitation rates using objective health measures and prior utilization. Health Care Financ Rev 1989; 10 (3): 41-54
25. Newhouse JP, Sloss EM, Manning Jr WG, et al. Risk adjustment for a children's capitation rate. Health Care Financ Rev 1993; 15 (1): 39-54
26. Cabana MD, Slish KK, Nan B, et al. Limits of the HEDIS criteria in determining asthma severity for children. Pediatrics 2004 Oct; 114 (4): 1049-55
27. Neff JM, Sharp VL, Muldoon J, et al. Identifying and classifying children with chronic conditions using administrative data with the clinical risk group classification system. Ambul Pediatr 2002 Jan-Feb; 2 (1): 71-9
28. Bethell C, Read D. Approaches to identifying children and adults with special health care needs: a resource manual for state Medicaid agencies and managed care organizations. Portland (OR): The Child and Adolescent Health Measurement Initiative, Oregon Health and Science University, 2002
29. Economic Research Service. Rural-urban commuting area codes. Washington, DC: US Department of Agriculture, 2000 [online]. Available from URL: http://www.ers.usda.gov/Data/ RuralUrbanCommutingAreaCodes/ [Accessed 2010 Aug 18]
30. Duan N. Smearing estimate: a nonparametric retransformation method. J Am Stat Assoc 1983; 78 (383): 605-10
31. Stata/MP [computer program]. Version 11. College Station (TX): StataCorp, 2009
32. Mattke S, Martorell F, Hong SY, et al. Anti-inflammatory medication adherence and cost and utilization of asthma care in a commercially insured population. J Asthma 2010 Apr; 47 (3): 323-9
33. Linden AL. What will it take for disease management to demonstrate a return on investment? New perspectives on an old theme. Am J Manag Care 2006 Apr; 12 (4): 217-22
34. Farber HJ, Capra AM, Finkelstein JA, et al. Misunderstanding of asthma controller medications: association with nonadherence. J Asthma 2003; 40 (1): 17-25
35. Naimi DR, Freedman TG, Ginsburg KR, et al. Adolescents and asthma: why bother with our meds? J Allergy Clin Immun 2009 Jun; 123 (6): 1335-41
36. Bravata DM, Gienger AL, Holty JE, et al. Quality improvement strategies for children with asthma: a systematic review. Arch Pediatr Adolesc Med 2009 Jun; 163 (6): 572-81